ERBB2 and breast cancer: We observed that pCR rate was significantly different in different molecular subgroups (HR+HER2‐, HER2+, and TNBC) (p = 0.02), and the pCR rate of HER2+ and TNBC BC was significantly higher than that of HR+HER2‐.